Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PAK4/PAK5/PAK6 (pSer560) anticorps

Reactivité: Humain, Souris, Rat WB, FACS, IF (cc), IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN744473
  • Antigène
    PAK4/PAK5/PAK6
    Épitope
    • 14
    • 4
    • 2
    • 1
    • 1
    pSer560
    Reactivité
    Humain, Souris, Rat
    Hôte
    • 18
    Lapin
    Clonalité
    • 16
    • 2
    Polyclonal
    Conjugué
    • 6
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Inconjugué
    Application
    • 17
    • 10
    • 10
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
     Réactivité croisée
    Humain, Souris, Rat
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic phosphopeptide derived from human PAK4 around the phosphorylation site of PAK4 Ser474 [RK(p-S)LV]
    Isotype
    IgG
  • Indications d'application
    WB(1:100-1000), IHC-P(1:100-500), IF(IHC-P)(1:50-200)
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C for 12 months.
    Date de péremption
    12 months
  • Choi, Yeon, Ryu, Kim, Moon, Lee, Lee, Lee, Heo, Park, Kim: "Repositioning Potential of PAK4 to Osteoclastic Bone Resorption." dans: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, (2015) (PubMed).

  • Antigène
    PAK4/PAK5/PAK6
    Sub Type
    Cocktail
    Sujet

    Synonyms: PAK4Ser474, PAK5Ser602, PAK6Ser560, p21 activated kinase 4 , p21CDKN1A activated kinase 4, PAK 4, Protein kinase related to S.cerevisiae STE20 effector for Cdc42Hs, Serine threonine kinase PAK 4, Serine/threonine protein kinase PAK 4, Serine/threonine protein kinase PAK4, KIAA1142, PAK4_HUMAN.

    Background: p21-activated kinases (PAKs) belong to the family of serine/threonine kinases involved in the control of various cellular processes, including the cell cycle, dynamics of the cytoskeleton, apoptosis, oncogenic transformation, and transcription. All PAK family members are characterized by the presence of p21-binding domain. p21-activated kinases are regulated by the small GTP-binding proteins Rac and Cdc42, and lipids, which stimulate autophosphorylation and phosphorylation of exogenous substrates. Serine (Ser-474) is the likely autophosphorylation site in the kinase domain of PAK4 in vivo. Phosphospecific directed against serine 474 detect activated PAK4 on the Golgi membrane when PAK4 is co-expressed with activated Cdc42. Current data strongly implicates PAK-4 in oncogenesis. PAK4 is frequently overexpressed in human tumor cell lines of various tissue origins.

    ID gène
    10298
Vous êtes ici:
Support technique